This consensus statement provides a standardized template for the medical and interventional management of intracranial atherosclerotic disease and outlines future research priorities.
No takes yet. Share an insight, caveat, or question.
Standardizes ICAD care favoring antiplatelets and selective stenting; extends prior evidence by defining research priorities.
Qureshi et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: